20.500.12556/DiRROS-14591
Neutralizing anti-interferon-[gamma] autoantibodies: an ameliorating factor in COVID-19 infection?
SARS-CoV-2
COVID-19
interferon-gamma
respiratory distress syndrome
nontuberculous mycobacteria
macrophage activation syndrome
acute respiratory distress syndrome
SARS-CoV-2
covid-19
interferon gama
sindrom dihalne stiske
netuberkulozne mikobakterije
sindrom aktivacije makrofago
vsindrom akutne dihalne stiske
true
false
true
Springer Nature
Angleški jezik
Ni določen
(c)The Author(s)
Neznano
2021-11-09 14:56:30
2021-11-09 14:56:30
2022-08-20 03:36:30
0000-00-00 00:00:00
2021
0
Nizozemska
0
Nasl. z nasl. zaslona;
"Mark Kacar and Paulina Cortes-Acevedo contributed equally to this work.";
Opis vira z dne 5. 11. 2021;
str. 1531-1535
iss. 7
Vol. 41
Oct. 2021
0000-00-00
Zaloznikova
Objavljeno
NiDoloceno
0000-00-00
0000-00-00
0000-00-00
616-097
1573-2592
10.1007/s10875-021-01102-7
83776771
https://link.springer.com/content/pdf/10.1007/s10875-021-01102-7.pdf
1
https://dirros.openscience.si/Dokument.php?lang=slv&id=18627
Univerzitetna klinika za pljučne bolezni in alergijo Golnik
0
0
0